nach oben

Erschienen in:

29.08.2023 | Original Article

Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population

verfasst von: Alice Faure, Mirna Haddad, Jessica Pinol, Thierry Merrot, Jean-Michel Guys, Floriane Michel, Gilles Karsenty

Erschienen in: World Journal of Urology | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To present our initial experience with periurethral adjustable continence therapy (ACT™) for urinary incontinence due to intrinsic sphincter deficiency (ISD) in children.

Methods

This is an approved prospective non-randomized pilot study (NCT03351634) aiming to treat children born with spinal dysraphism (SD) or exstrophy epispadias complex (EEC) with ACT™. Endpoints were patient-reported changes in daily pad count, 24-h Pad test and complications.

Results

Since April 2018, 13 children (six girls, seven boys) were implanted at the median age of 12 years (5–16). The etiology of incontinence was neurogenic ISD (7/13, 54%) and EEC (6/13, 46%).

After ACT™ implantation, continence (no pad or 1 security pad/day) was achieved in 9(69%) patients (5/7 SD, 4/6 EEC). Additionally, two (15%) patients had a significant improvement (decreasing Pad test from 1049 to 310 g at 3 months). One patient (7%) had no improvement. Results were stable at 21 months (6–43) of follow-up. Mean final balloon volume was 2.89 ml (± 0.85) with a median of 3 fillings to obtain continence.

We had four revisions due to cutaneous port erosion (n = 3) and balloon migration (n = 1) and two definitive explantations. PinQ score was significantly improved (47 vs 40.5 with balloon, p = ns). Neither degradation of the upper urinary tract nor cystomanometric changes have been observed at 6 and 12 months postoperatively.

Conclusion

Urinary incontinence due to ISD owing to EEC or SD can be successfully treated with ACT™ periurethral balloons. Given the minimal invasiveness of this therapy, it might be a first‐line option treatment in children with complex stress urinary incontinence.

Nur mit Berechtigung zugänglich

Rawashdeh YF, Austin P, Siggaard C et al (2012) International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn 31(5):615–620. https://doi.org/10.1002/nau.22248CrossRefPubMed

Guys JM, Hery G, Haddad M, Borrionne C (2011) Neurogenic bladder in children: basic principles, new therapeutic trends. Scand J Surg 100(4):256–263. https://doi.org/10.1177/145749691110000405CrossRefPubMed

Ludwikowski BM, Bieda JC, Lingnau A, González R (2019) Surgical management of neurogenic sphincter incompetence in children. Front Pediatr 7:97. https://doi.org/10.3389/fped.2019.00097CrossRefPubMedPubMedCentral

De Vocht TF, Chrzan R, Dik P, Klijn AJ, De Jong TPVM (2010) Long-term results of bulking agent injection for persistent incontinence in cases of neurogenic bladder dysfunction. J Urol 183(2):719–723. https://doi.org/10.1016/j.juro.2009.10.044CrossRefPubMed

Maruf M, Manyevitch R, Michaud J et al (2020) Urinary continence outcomes in classic bladder exstrophy: a long-term perspective. J Urol 203(1):200–205. https://doi.org/10.1097/JU.0000000000000505CrossRefPubMed

Johnston AW, Wiener JS, Todd PJ (2020) Pediatric neurogenic bladder and bowel dysfunction: will my child ever be out of diapers? Eur Urol Focus 6(5):838–867. https://doi.org/10.1016/j.euf.2020.01.003CrossRefPubMed

Faure A, Hery G, Mille E et al (2017) Long-term efficacy of young-Dees bladder neck reconstruction: role of the associated bladder neck injection for the treatment of children with urinary incontinence. Urology 108:166–170. https://doi.org/10.1016/j.urology.2017.06.005CrossRefPubMed

Alova I, Margaryan M, Bernuy M, Lortat-Jacob S, Lottmann HB (2012) Long-term effects of endoscopic injection of dextranomer/hyaluronic acid based implants for treatment of urinary incontinence in children with neurogenic bladder. J Urol 188(5):1905–1909. https://doi.org/10.1016/j.juro.2012.07.016CrossRefPubMed

Castellan M, Gosalbez R, Labbie A, Ibrahim E, Disandro M (2005) Bladder neck sling for treatment of neurogenic incontinence in children with augmentation cystoplasty: long-term followup. J Urol 173(6):2128–2131. https://doi.org/10.1097/01.ju.0000157688.41223.d2. (discussion 2131)CrossRefPubMed

10.

Noordhoff TC, van den Hoek J, Yska MJ, Wolffenbuttel KP, Blok BFM, Scheepe JR (2019) Long-term follow-up of bladder outlet procedures in children with neurogenic urinary incontinence. J Pediatr Urol 15(1):35.e1-35.e8. https://doi.org/10.1016/j.jpurol.2018.08.018CrossRefPubMed

11.

Simeoni J, Guys JM, Mollard P et al (1996) Artificial urinary sphincter implantation for neurogenic bladder: a multi-institutional study in 107 children. Br J Urol 78(2):287–293. https://doi.org/10.1046/j.1464-410x.1996.06126.xCrossRefPubMed

12.

Castera R, Podestá ML, Ruarte A, Herrera M, Medel R (2001) 10-year experience with artificial urinary sphincter in children and adolescents. J Urol 165(6 Pt 2):2373–2376. https://doi.org/10.1097/00005392-200106001-00039CrossRefPubMed

13.

Herndon CDA, Rink RC, Shaw MBK et al (2003) The Indiana experience with artificial urinary sphincters in children and young adults. J Urol 169(2):650–654. https://doi.org/10.1097/01.ju.0000047320.28201.9d. (discussion 654)CrossRefPubMed

14.

Mehnert U, Bastien L, Denys P et al (2012) Treatment of neurogenic stress urinary incontinence using an adjustable continence device: 4-year followup. J Urol 188(6):2274–2280. https://doi.org/10.1016/j.juro.2012.07.131CrossRefPubMed

15.

Kaboré FA, Gaillet S, Blanc J et al (2014) Initial results of adjustable periurethral balloons (ACT™ and pro ACT™) in the treatment of adult stress urinary incontinence with intrinsic sphincter deficiency. Prog Urol 24(17):1132–1138. https://doi.org/10.1016/j.purol.2014.08.004CrossRefPubMed

16.

Phé V, Nguyen K, Rouprêt M, Cardot V, Parra J, Chartier-Kastler E (2014) A systematic review of the treatment for female stress urinary incontinence by ACT^® balloon placement (Uromedica, Irvine, CA, USA). World J Urol 32(2):495–505. https://doi.org/10.1007/s00345-013-1117-0CrossRefPubMed

17.

Decter RM, Roth DR, Fishman IJ, Shabsigh R, Scott FB, Gonzales ET (1988) Use of the AS800 device in exstrophy and epispadias. J Urol 140(5 Pt 2):1202–1203. https://doi.org/10.1016/s0022-5347(17)42002-7CrossRefPubMed

18.

Chartier-Kastler E, Costa P, Ben Naoum K, Cour F, Le Normand L, Haab F (2007) French multicentre prospective study of the use of ACT balloons (Uromedica, Inc., Plymouth, Min, U.S.A.; Medtronic, Minneapolis, U.S.A.) for the treatment of female stress urinary incontinence. Prog Urol 17(7):1372–1377. https://doi.org/10.1016/s1166-7087(07)78580-9CrossRefPubMed

19.

Demeestere A, de Guerry ML, Bergot C et al (2022) Adjustable continence therapy (ACT^®) balloons to treat neurogenic and non-neurogenic female urinary incontinence. Neurourol Urodyn 41(1):313–322. https://doi.org/10.1002/nau.24822CrossRefPubMed

20.

Paret F, Leclair MD, Karam G, Rigaud J, Baron M, Perrouin-Verbe MA (2023) Long-term results of artificial urinary sphincter implantation for urinary incontinence due to intrinsic sphincter deficiency in children. Neurourol Urodyn 42(1):355–365. https://doi.org/10.1002/nau.25106CrossRefPubMed

21.

Ruiz E, Puigdevall J, Moldes J et al (2006) 14 years of experience with the artificial urinary sphincter in children and adolescents without spina bifida. J Urol 176(4 Pt 2):1821–1825. https://doi.org/10.1016/j.juro.2006.05.024CrossRefPubMed

22.

Ronzi Y, Le Normand L, Chartier-Kastler E et al (2019) Neurogenic stress urinary incontinence: is there a place for Adjustable Continence Therapy (ACT™ and ProACT™, Uromedica, Plymouth, MN, USA)? A retrospective multicenter study. Spinal Cord 57(5):388–395. https://doi.org/10.1038/s41393-018-0219-3CrossRefPubMed

23.

Ammirati E, Manassero A, Giammò A, Carone R (2017) Management of male and female neurogenic stress urinary incontinence in spinal cord injured (SCI) patients using adjustable continence therapy. Urologia 84(3):165–168. https://doi.org/10.5301/uj.5000242CrossRefPubMed

24.

Musco S, Padilla-Fernández B, Del Popolo G et al (2018) Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: a systematic review. Neurourol Urodyn 37(5):1522–1540. https://doi.org/10.1002/nau.23501CrossRefPubMed

25.

Catti M, Lortat-Jacob S, Morineau M, Lottmann H (2008) Artificial urinary sphincter in children–voiding or emptying? An evaluation of functional results in 44 patients. J Urol 180(2):690–693. https://doi.org/10.1016/j.juro.2008.04.039. (discussion 693)CrossRefPubMed

26.

Bajeot AS, Brierre T, Beauval JB et al (2021) Survival analysis of adjustable continence therapy device (ACT^®/proACT^®): a new message for patients. Prog Urol 31(4):215–222. https://doi.org/10.1016/j.purol.2020.10.005CrossRefPubMed

Titel: Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population
verfasst von: Alice Faure
Mirna Haddad
Jessica Pinol
Thierry Merrot
Jean-Michel Guys
Floriane Michel
Gilles Karsenty
Publikationsdatum: 29.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 10/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04550-5

Neu im Fachgebiet Urologie

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population